10-Q: Insperity Reports Q1 2025 Results: Revenue Up, Earnings Down Amid Rising Costs

Sentiment:

Quarterly Report


Insperity's Q1 2025 shows revenue growth but a decline in net income and EPS due to increased direct costs, particularly in health insurance.

Worse than expectedNet income and diluted EPS both decreased by 35% due to higher direct costs.Adjusted EBITDA decreased by 28%.

Summary

  • Insperity, Inc. reported its Q1 2025 financial results, showing a 3% increase in revenue to $1.863 billion compared to $1.802 billion in Q1 2024.
  • However, net income decreased by 35% to $51 million, and diluted earnings per share (EPS) also fell by 35% to $1.35.
  • Adjusted net income decreased 31% to $59 million, and adjusted EPS decreased 31% to $1.57.
  • Adjusted EBITDA decreased 28% to $102 million.
  • The average number of worksite employees (WSEEs) paid per month increased by 1% to 306,023.
  • Gross profit decreased by 10% to $310 million, primarily due to higher direct costs.
  • Health insurance costs increased significantly, driven by higher claim activity.
  • Workers compensation costs also saw an increase.
  • Operating expenses increased by 2% to $242 million.
  • The company amended its credit facility to exclude dividends from the interest coverage ratio financial covenant.

Sentiment

Score: 5

Explanation: The document presents mixed results, with revenue growth offset by declining earnings and rising costs. The outlook is cautious due to various economic and operational risks.

Positives

  • Revenue increased by 3% compared to the same quarter last year.
  • The average number of WSEEs paid increased by 1%.

Negatives

  • Net income and diluted EPS both decreased by 35%.
  • Adjusted EBITDA decreased by 28%.
  • Gross profit decreased by 10% due to higher direct costs.
  • Health insurance costs increased significantly, driven by higher claim activity.
  • Workers compensation costs also saw an increase.

Risks

  • Adverse economic conditions could impact client businesses and WSEE levels.
  • Increases in health insurance and workers compensation costs could reduce profitability.
  • Failure to manage growth and maintain client retention could impact revenue.
  • Disruptions to information technology systems could impact service delivery.
  • Inability to fully realize the benefits of the Workday partnership could affect future growth.

Future Outlook

The document contains forward-looking statements regarding business plans, strategies, anticipated benefits, and projections involving revenues, earnings, WSEEs, and operating results, all of which are subject to risks and uncertainties.

Management Comments

  • Management believes it has valid defenses in various lawsuits and claims and is defending them vigorously.
  • Management believes the final outcome of such litigation will not have a material adverse effect on our financial position or results of operations.

Industry Context

The document mentions the competitive environment and other developments in the human resources services industry, including the professional employer organization (PEO) industry, as factors impacting growth and profitability. It also references a strategic partnership with Workday, Inc., indicating a focus on technology and service offerings to address new regulations and client expectations.

Comparison to Industry Standards

  • The document does not provide specific comparisons to industry standards or competitors.
  • However, it mentions monitoring key metrics such as WSEEs, Adjusted EBITDA, and Adjusted EPS, which are common performance indicators in the PEO industry.
  • Companies like ADP, TriNet, and Paychex are key competitors in the PEO and HR outsourcing space, and their performance can be used as a benchmark for Insperity's results.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Credit Agreement AmendmentThe company amended its credit facility to exclude dividends from the interest coverage ratio financial covenant and added a Special Unmatured Event of Default clause.March 31, 2025This change provides more flexibility in dividend payments but also introduces a new restriction related to potential defaults.

Legal Proceedings

  • The company is a defendant in various lawsuits and claims arising in the normal course of business.
  • Management believes the final outcome of such litigation will not have a material adverse effect on our financial position or results of operations.

Stakeholder Impact

  • Shareholders: Impacted by decreased net income and EPS.
  • Employees: Affected by potential cost-cutting measures to address rising expenses.
  • Clients: May experience changes in pricing or service offerings as the company manages costs.
  • Creditors: Impacted by the amendment to the credit facility.

Next Steps

  • The company will continue to monitor its liquidity requirements and capital needs.
  • The company will focus on managing direct costs and maintaining client retention.
  • The company will continue to evaluate potential acquisitions and strategic partnerships.

Key Dates

DateDescription
February 6, 2018Original Amended and Restated Credit Agreement date.
December 31, 2024Date used for comparison in the balance sheet and reference point for risk factor disclosures.
March 26, 2025Date of letter agreement with UnitedHealthcare.
March 31, 2025End of the reporting period for the first quarter of 2025; effective date of the Seventh Amendment to the Credit Agreement.
April 22, 2025Date as of which the number of outstanding shares of common stock is reported (37,626,529 shares).
April 28, 2025Date of execution of the Seventh Amendment to Amended and Restated Credit Agreement.
April 29, 2025Date of report filing and certifications.
June 30, 2027Maturity date of the revolving credit facility.

Keywords

Insperity, financial results, Q1 2025, WSEEs, revenue, net income, EPS, EBITDA, health insurance, workers compensation, PEO, HR outsourcing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.